← back to search

Tim Peto

John Radcliffe Hospital · GB
Area of research
Infectious Diseases · Molecular Medicine
Research interest
Research interests include Antibiotic Resistance in Bacteria, Mycobacterium research and diagnosis, SARS-CoV-2 and COVID-19 Research, and Bacterial Identification and Susceptibility Testing.
h-index
111
citations
44,889
works
544
NIH funding
primary concept
Medicine
email

Recent publications

An improved catalogue for whole-genome sequencing prediction of bedaquiline resistance in Mycobacterium tuberculosis using a reproducible algorithmic approach
Microbial Genomics 2025cited by 4position: contributordoi
The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study
2025cited by 1position: contributordoi
Social behaviours and contact patterns across the 2020/21, 2021/22 and 2022/23 winter seasons in the UK, and associations with symptoms
2025cited by 1position: contributordoi
An improved catalogue for whole-genome sequencing prediction of bedaquiline resistance in <i>M. tuberculosis</i> using a reproducible algorithmic approach
2025cited by 0position: contributordoi
Author response: The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study
2025cited by 0position: contributordoi
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach
Nature Communications 2024cited by 45position: middledoi
The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study
2024cited by 5position: contributordoi
The impact of different antimicrobial exposures on the gut microbiome in the ARMORD observational study
2024cited by 0position: contributordoi
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
New England Journal of Medicine 2022cited by 503position: lastdoi
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis
The Lancet Microbe 2022cited by 298position: middledoi
Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank
Nature Communications 2022cited by 106position: middledoi
High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
Genome Medicine 2022cited by 48position: middledoi
Health record hiccups-5,526 real-world time series with change points labelled by crowdsourced visual inspection.
2022cited by 2position: contributordoi
SARS-CoV-2 within-host diversity and transmission.
2021cited by 345position: contributordoi
Antimicrobial resistance in commensal opportunistic pathogens isolated from non-sterile sites can be an effective proxy for surveillance in bloodstream infections
Scientific Reports 2021cited by 8position: middledoi
Daily contact testing schools and colleges trial
http://isrctn.com/ 2021cited by 1position: contributordoi
Antimicrobial resistance determinants are associated with <i>Staphylococcus aureus</i> bacteraemia and adaptation to the hospital environment: a bacterial genome-wide association study
2021cited by 0position: contributordoi
Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne <i>bla</i> <sub>KPC</sub> Carbapenemase in <i>Enterobacterales</i> in the United Kingdom from 2009 to 2014
Antimicrobial Agents and Chemotherapy 2020cited by 47position: middledoi
An ecological comparison of hospital-level antibiotic use and mortality in 36,124,372 acute/general medicine inpatients in England
2020cited by 1position: contributordoi
SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex.
2019cited by 62position: contributordoi
The Spatial Morphology of Intraluminal Thrombus Influences Type II Endoleak after Endovascular Repair of Abdominal Aortic Aneurysms
Annals of Vascular Surgery 2019cited by 24position: middledoi
Epidemiology of paediatric gastrointestinal colonisation by extended spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-west Cambodia.
2019cited by 19position: contributordoi
Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: Observational analyses within the ARREST trial.
2019cited by 13position: contributordoi
WGS to determine the extent of Clostridioides difficile transmission in a high incidence setting in North Wales in 2015.
2019cited by 8position: contributordoi
Antibiotic Review Kit for Hospitals (ARK-Hospital): study protocol for a stepped-wedge cluster-randomised controlled trial.
2019cited by 6position: contributordoi
The Hospital Water Environment as a Reservoir for Carbapenem-Resistant Organisms Causing Hospital-Acquired Infections—A Systematic Review of the Literature
Clinical Infectious Diseases 2017cited by 380position: middledoi
Some Synonymous and Nonsynonymous <i>gyrA</i> Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDR <i>sl</i> Assays
Antimicrobial Agents and Chemotherapy 2017cited by 35position: middledoi
The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee
Clinical Microbiology and Infection 2016cited by 572position: middledoi
Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131
mBio 2016cited by 348position: middledoi
Nested Russian Doll-Like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene <i>bla</i> <sub>KPC</sub>
Antimicrobial Agents and Chemotherapy 2016cited by 324position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Derrick W. Crook · Nuffield Orthopaedic Centre19 papers (2012–2025)A. Sarah Walker · The Royal Free Hospital11 papers (2019–2025) · 11 papers (2020–2025)Nicole Stoesser · Nuffield Orthopaedic Centre8 papers (2012–2025)Martin J. Llewelyn · National Institute for Health Research8 papers (2019–2025) · 7 papers (2021–2025)A. Sarah Walker · Health Protection Scotland7 papers (2012–2022)Nicola Fawcett · University of Oxford4 papers (2024–2025) · 4 papers (2024–2025)Leon Peto · University of Oxford4 papers (2024–2025)Catrin E. Moore · Institute for Health Metrics and Evaluation3 papers (2015–2019)David W. Eyre · Health Protection Scotland3 papers (2013–2022)Shaheed Vally Omar · National Institute for Communicable Diseases3 papers (2017–2025)Anna E. Sheppard · University of Auckland3 papers (2015–2016)Daniel J. Wilson · University of California, Berkeley3 papers (2013–2016)Andrew Kasarskis · Sema4 (United States)2 papers (2016–2016)James R. Johnson · Wake Forest University2 papers (2015–2016)Xavier Didelot · UK Health Security Agency2 papers (2013–2016)Claudio U. Köser · Cambridge University Hospitals NHS Foundation Trust2 papers (2016–2017)Amy J. Mathers · University of Virginia Health System2 papers (2016–2017)